Sheng-Chieh Chou, MD.

Hematologist
Department of Internal Medicine, National Taiwan University Hospital
Taipei, Taipei, Taiwan (Republic of China)

Dr. Sheng-Chieh Chou obtained his medical degree at Tzu-Chi Medical University. He completed training of internal medicine and fellowship of hematology in National Taiwan University Hospital (NTUH).
Dr. Chou has practiced as a hematologist at NTUH since 2009 and interested in the field of thrombosis and hemostasis. He participated in many clinical trials of hemophilia and other rare diseases. Currently he is director of hemophilia center of NTUH, which taking care of more than 100 patients with bleeding disorders.

Presentation(s):

• PB0229 - Results from the Taiwanese cohort in GENEr8-1: bleeding rates, factor VIII usage, quality of life and safety in severe Hemophilia A patients after gene therapy

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1

  Monday, June 24, 2024
  09:45 – 10:00 ICT

• OC 30.3 - Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec

  Monday, June 24, 2024
  10:00 – 10:15 ICT

• OC 41.5 - Evaluation of factor VIII inhibitor risk under emicizumab prophylaxis using hemophilia A murine models with long-term expression of human factors IX and X

  Monday, June 24, 2024
  15:45 – 16:00 ICT

• OC 50.2 - Long-term outcomes with efanesoctocog alfa prophylaxis for previously treated children with severe hemophilia A, an interim analysis of the phase 3 XTEND-ed study

  Tuesday, June 25, 2024
  09:45 – 10:00 ICT